Altius

ALTIUS is an independent Belgian law firm based in Brussels (Tour & Taxis). ALTIUS currently has 65 lawyers and 25 staff members. We are a full-service law firm and we advise Belgian and international companies on the legal aspects of their businesses, transactions and disputes.

At ALTIUS, we do legal differently. Going the extra mile and challenging the status quo is the way we work with every colleague, client and business partner. We are looking for candidates who are motivated to go the extra mile, are open minded, deliver quality and are not afraid to challenge and be challenged.

FONDÉ

2002

RÉGION
  • Bruxelles
PRINCIPALES ACTIVITÉS
  • Droit commercial et contrats
  • Droit des sociétés
  • Droit civil
  • Droit fiscal
  • Droit public et administratif
  • Droit de l'immobilier
  • Litiges et arbitrage/médiation
  • Droit financier et bancaire
  • Propriété intéllectuelle
  • Droit des assurances
  • Régulation financière
  • Planification patrimoniale
  • Protection des données et de la vie privée
  • Employee benefits & pensions
  • Technologie, média et télécommunications
  • Droit pénal
  • Droit européen
  • M&A / Private equity
  • Droit de l'énergie
  • Droit de la concurrence
  • Droit du transport
  • Droit de l'environnement et de l'urbanisme
  • Droit du travail et sécurité sociale
  • Autre matière
  • Droit médical et biomédical
  • Droit des entreprises en difficulté
Google Maps
Google Maps
Belgian Competition Authority fines kitchen accessories company Le Creuset for resale price maintenance

Antitrust issues in vertical relationships are no longer below the competition authorities’ ‘radar’. This trend of not only focusing on horizontal but…

EU citizens rally for medical cannabis but face a rigid European Commission

In the EU, access to medical cannabis is a matter of national policy. A group of citizens wants to change that by leveraging a citizens’ initiative an…

The 5 major changes in Belgian pharma law of 2023

Both the Belgian legislator and government have played an active role in 2023 when it comes to pharma legislation, which has led to a number of change…